Pharmacokinetics, Safety and Inducible Cytokine Responses during a Phase 1 Trial of the Oral Histone Deacetylase Inhibitor ITF2357 (Givinostat)

Overview of attention for article published in Molecular Medicine, February 2011

Altmetric Badge

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 94 Dimensions

Readers on

mendeley: 67 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

HISTONE DEACETYLASE INHIBITORS AND USES THEREOF

Application WO-2022058405-A2

World Intellectual Property Organisation (WIPO)

COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE…

Application WO-2012120262-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.